These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38234861)

  • 1. Letter to the Editors: Concerning "Hyperleucinosis during infections in maple syrup urine disease post-liver transplantation" by Guilder et al.
    Takano C; Ogawa E; Arai-Ichinoi N; Ishige M
    Mol Genet Metab Rep; 2024 Mar; 38():101047. PubMed ID: 38234861
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperleucinosis during infections in maple syrup urine disease post liver transplantation.
    Guilder L; Prada CE; Saenz S; Jain-Ghai S; Karp N; Mazariegos G; Ratko S; Salvarinova R; Mercimek-Andrews S
    Mol Genet Metab Rep; 2021 Jun; 27():100763. PubMed ID: 33996492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definition of the mutation responsible for maple syrup urine disease in Poll Shorthorns and genotyping Poll Shorthorns and Poll Herefords for maple syrup urine disease alleles.
    Dennis JA; Healy PJ
    Res Vet Sci; 1999 Aug; 67(1):1-6. PubMed ID: 10425233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease.
    Zinnanti WJ; Lazovic J; Griffin K; Skvorak KJ; Paul HS; Homanics GE; Bewley MC; Cheng KC; Lanoue KF; Flanagan JM
    Brain; 2009 Apr; 132(Pt 4):903-18. PubMed ID: 19293241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mid-term outcome of 2 cases with maple syrup urine disease: role of liver transplantation in the treatment].
    Netter JC; Cossarizza G; Narcy C; Hubert P; Ogier H; Revillon Y; Rabier D; Saudubray JM
    Arch Pediatr; 1994 Aug; 1(8):730-4. PubMed ID: 7842107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transplantation from a live donor to a patient with maple syrup urine disease: Two case reports.
    Baştürk A; Keçeli M; Erbiş H; Soyucen E; Aliosmanoğlu İ; Dinçkan A; Yılmaz A; Artan R
    Turk Pediatri Ars; 2018 Jun; 53(2):113-116. PubMed ID: 30116132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4,5-dimethyl-3-hydroxy-2[5H]-furanone (sotolone)--the odour of maple syrup urine disease.
    Podebrad F; Heil M; Reichert S; Mosandl A; Sewell AC; Böhles H
    J Inherit Metab Dis; 1999 Apr; 22(2):107-14. PubMed ID: 10234605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technique and outcome of domino liver transplantation from patients with maple syrup urine disease: Expanding the donor pool for live donor liver transplantation.
    Celik N; Kelly B; Soltys K; Squires JE; Vockley J; Shellmer DA; Strauss K; McKiernan P; Ganoza A; Sindhi R; Bond G; Mazariegos G; Khanna A
    Clin Transplant; 2019 Nov; 33(11):e13721. PubMed ID: 31556146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maple Syrup Urine Disease Masquerading as Urea Cycle Disorder: A Tale of Two Clinical Mimics.
    Rauf S; Almas T; Ullah I; Usman N; Irfan M
    Cureus; 2020 Aug; 12(8):e9706. PubMed ID: 32944429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two consecutive partial liver transplants in a patient with Classic Maple Syrup Urine Disease.
    Chin HL; Aw MM; Quak SH; Huang J; Hart CE; Prabhakaran K; Goh DL
    Mol Genet Metab Rep; 2015 Sep; 4():49-52. PubMed ID: 26937410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Control and "Ideal" Outcomes in Liver Transplantation for Maple Syrup Urine Disease.
    Ewing CB; Soltys KA; Strauss KA; Sindhi R; Vockley J; McKiernan P; Squires RH; Bond G; Ganoza A; Khanna A; Mazariegos GV; Squires JE
    J Pediatr; 2021 Oct; 237():59-64.e1. PubMed ID: 34153280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of maple syrup urine disease: Benefits, risks, and challenges of liver transplantation.
    Deon M; Guerreiro G; Girardi J; Ribas G; Vargas CR
    Int J Dev Neurosci; 2023 Oct; 83(6):489-504. PubMed ID: 37340513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Living related versus deceased donor liver transplantation for maple syrup urine disease.
    Feier F; Schwartz IV; Benkert AR; Seda Neto J; Miura I; Chapchap P; da Fonseca EA; Vieira S; Zanotelli ML; Pinto e Vairo F; Camelo JS; Margutti AV; Mazariegos GV; Puffenberger EG; Strauss KA
    Mol Genet Metab; 2016 Mar; 117(3):336-43. PubMed ID: 26786177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical technique and the long-term outcomes of pediatric living donor domino liver transplantation from patients with maple syrup urine disease.
    Shimizu S; Sakamoto S; Fukuda A; Yanagi Y; Uchida H; Mimori K; Nakao T; Sun C; Horikawa R; Kasahara M
    Pediatr Transplant; 2022 Mar; 26(2):e14174. PubMed ID: 34687480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroradiological findings in maple syrup urine disease.
    Indiran V; Gunaseelan RE
    J Pediatr Neurosci; 2013 Jan; 8(1):31-3. PubMed ID: 23772241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Branched-chain α-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes.
    Strauss KA; Carson VJ; Soltys K; Young ME; Bowser LE; Puffenberger EG; Brigatti KW; Williams KB; Robinson DL; Hendrickson C; Beiler K; Taylor CM; Haas-Givler B; Chopko S; Hailey J; Muelly ER; Shellmer DA; Radcliff Z; Rodrigues A; Loeven K; Heaps AD; Mazariegos GV; Morton DH
    Mol Genet Metab; 2020 Mar; 129(3):193-206. PubMed ID: 31980395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver transplantation for classical maple syrup urine disease.
    Buss P; Tornberg DN
    Am J Transplant; 2006 Aug; 6(8):1982; author reply 1983. PubMed ID: 16796715
    [No Abstract]   [Full Text] [Related]  

  • 18. Maple Syrup Urine Disease and Domino Liver Transplantation: When and How?
    Spada M; Angelico R; Dionisi-Vici C
    Liver Transpl; 2019 Jun; 25(6):827-828. PubMed ID: 31038782
    [No Abstract]   [Full Text] [Related]  

  • 19. Liver transplantation for maple syrup urine disease: A global domino effect.
    Celik N; Squires RH; Vockley J; Sindhi R; Mazariegos G
    Pediatr Transplant; 2016 May; 20(3):350-1. PubMed ID: 27038300
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictors of acute metabolic decompensation in children with maple syrup urine disease at the emergency department.
    Yıldız Y; Akcan Yıldız L; Dursun A; Tokatlı A; Coşkun T; Tekşam Ö; Sivri HS
    Eur J Pediatr; 2020 Jul; 179(7):1107-1114. PubMed ID: 32048023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.